Multidisciplinary | Home | MIMS Singapore

Multidisciplinary

Top Medical News
Men with premature ejaculation cope by having repeated sex in a day
18 hours ago
Patients with premature ejaculation (PE) tend to engage in multiple turns of sexual intercourse within a single day in an attempt to compensate for their first unsatisfactory sexual encounter, suggests a study.
Legume intake reduces colorectal cancer risk
Stephen Padilla, 19 hours ago
Eating legumes may help avert the development of colorectal cancer, according to a study that has found an inverse association between legume consumption and colorectal cancer risk.
Is a low-GI Mediterranean diet better for people with high cardiometabolic risk?
20 hours ago
A low-glycaemic index (GI) diet, based on a Mediterranean dietary (MedDiet) pattern, provides no substantial impact on major cardiometabolic risk factors at fasting in individuals at high cardiometabolic risk when compared with a high-GI MedDiet, a study has shown.
Tobacco smoke exposure early in life ups paediatric IBD risk
Audrey Abella, 21 hours ago
A Scandinavian population-based birth cohort study reveals that children who were exposed to tobacco smoke during their early childhood have an increased risk of developing inflammatory bowel disease (IBD) later in life.
Which diet is perfect for Parkinson’s disease patients?
Yesterday
A dietary pattern intervention may offer some help in reducing the symptoms of Parkinson’s disease (PD), including both motor and nonmotor symptoms, reports a study.
Low-dose aspirin for AMD prevention? ASPREE data show no benefit
Jairia Dela Cruz, 2 days ago
Use of aspirin at 100 mg per day proved unsuccessful at reducing the incidence of age-related macular degeneration (AMD) in a large cohort of older healthy individuals, according to medium-term data from the AMD substudy of the Aspirin in Reducing Events in the Elderly (ASPREE) trial.
Progesterone-to-estradiol ratio a promising treatment target in AUD
2 days ago
In adults with alcohol use disorder (AUD), high progesterone-to-estradiol ratios appear protective against problematic alcohol consumption, as shown in a study. Additionally, women with AUD may derive benefits from treatments tailored to their menstrual cycle phase.
Special Reports
Debunking the myths about DPP-4 inhibitors
01 May 2024
Navigating the evolving landscape of diabetes management requires precise knowledge. In this exploration into the world of DPP-4 inhibitors (DPP4is), we aim to debunk prevalent myths and provide nuanced insights.
Product Highlight - MENQUADFI
13 Apr 2024
Meningococcal group A, C, W & Y conjugate vaccine 0.5 mL solution for injection
Product Highlight - LYPSTAPLUS
11 Apr 2024
Rosuvastatin + Ezetimibe 10/10 mg and 20/10 mg film-coated tablet
Nirmatrelvir reduces the risk of long COVID
05 Mar 2024

Post-COVID condition, also known as long COVID, is a serious public health problem affecting millions of people around the world.1

COVID-19, influenza, death, hospital admission, adverse outcome
07 Feb 2024
A comparative analysis has shown that COVID-19 is distinctly more severe than seasonal influenza, with significantly increased long-term risks of adverse health outcomes and burdens.1
fenofibrate, metabolic syndrome, statins, omega-3 fatty acids, MACE
05 Feb 2024
A nationwide population-based cohort study in South Korea compared the effectiveness of omega-3 fatty acids and fenofibrate for reducing major adverse cardiovascular events (MACE) in individuals with metabolic syndrome (≥30 years) on statin therapy.1
Treating type 2 diabetes mellitus with G.R.A.C.E.
22 Jan 2024
A challenging aspect of glycaemic control presents in patients diagnosed with early-onset type 2 diabetes mellitus (T2DM). Considering this challenge, how can effective management of glycaemic control be achieved in patients with uncontrolled T2DM who are hesitant to incorporate multiple oral antidiabetic drugs into their current regimen? In this case study, Dr Matthew Tan shared his clinical experience in managing a young adult patient with T2DM using GLYXAMBI®, a fixed-dose combination of empagliflozin and linagliptin taken once daily. He demonstrated how applying the G.R.A.C.E. concept to the treatment improved the patient’s clinical outcome.

This advertorial is sponsored as an educational programme by Boehringer Ingelheim Singapore Pte. Ltd.
Conference Reports
Tobacco smoke exposure early in life ups paediatric IBD risk
Audrey Abella, 03 Jun 2024
A Scandinavian population-based birth cohort study reveals that children who were exposed to tobacco smoke during their early childhood have an increased risk of developing inflammatory bowel disease (IBD) later in life.
Musculoskeletal ultrasound for gout diagnosis: Why and how?
Sarah Cheung, 30 May 2024

Musculoskeletal ultrasound (MSUS) is a convenient and effective imaging tool for detecting urate deposition in the joints of patients with gout and those with asymptomatic hyperuricaemia.

Kids with medical complexity have poor oral health
Audrey Abella, 30 May 2024
A study presented at PAS 2024 shows that children with medical complexity (CMC) have poor oral health compared with children with special health care needs (CSHCN).
Increasing trend in DOAC-related intracerebral haemorrhage: How to improve outcomes?
Sarah Cheung, 30 May 2024
New local findings presented at HKMF 2024 show an increasing trend in intracerebral haemorrhage (ICH) among patients on direct oral anticoagulants (DOACs) between 2013 and 2022. Early initiation of reversal agents may improve outcomes in select cases with DOAC-related ICH.
48-week data ASSERT odevixibat’s role in ALGS
Audrey Abella, 29 May 2024
Pooled analysis of the ASSERT and ASSERT-EXT studies show sustained improvements in multiple parameters with odevixibat in individuals with Alagille syndrome (ALGS), thus reinforcing its role in the treatment of this multisystem genetic disorder.
Dupilumab sustains histological remission in children with EoE
Elaine Soliven, 29 May 2024

Treatment with higher-dose dupilumab results in sustained improvements in histologic and endoscopic measures of eosinophilic esophagitis (EoE) in children, regardless of prior use of swallowed topical corticosteroids (STCs), according to a subanalysis presented at ESPGHAN 2024.

Diversity of children included in clinical trials
Mike Ng, 28 May 2024
Maralixibat may have a role in treating a broader profile of children with PFIC, including those who have had biliary diversion surgery and those with MDR3 deficiency, suggest subgroup analyses from the phase III MARCH/MARCH-ON trials